Maximum Colchicine Dosing for Pericarditis
For acute pericarditis, the maximum dose is 0.5 mg twice daily (1.0 mg total daily) for patients ≥70 kg or 0.5 mg once daily for patients <70 kg, continued for 3 months. 1, 2
Standard Dosing by Weight and Duration
Acute Pericarditis (First Episode)
- Patients ≥70 kg: 0.5 mg twice daily (maximum 1.0 mg/day) 1, 2
- Patients <70 kg: 0.5 mg once daily (maximum 0.5 mg/day) 1, 2
- Duration: 3 months 1, 3, 2
Recurrent/Chronic Pericarditis
- Same weight-based dosing as acute pericarditis 3
- Duration: Minimum 6 months for recurrent disease 3
- The European Society of Cardiology demonstrated that this regimen reduces recurrence rates from 55% to 24% at 18 months 3
Critical Dose Adjustments for Renal Impairment
Colchicine is contraindicated in severe renal impairment and requires substantial dose reduction in moderate-to-severe kidney disease. 1
Renal Dosing Algorithm
- CrCl 30-50 mL/min (moderate impairment): Standard dose acceptable but requires close monitoring for toxicity 1
- CrCl <30 mL/min (severe impairment): 0.3 mg once daily maximum 1
- Dialysis patients: 0.3 mg twice weekly maximum 1, 4
FDA Maximum Dosing Limits
The FDA label specifies absolute maximum daily doses that should never be exceeded 4:
- Without drug interactions: Maximum 1.2-2.4 mg/day 4
- With P-gp inhibitors (cyclosporine, ranolazine): Maximum 0.6 mg/day 4
- With protease inhibitors: Maximum 0.6 mg/day 4
Important Drug Interaction Adjustments
When colchicine is combined with strong CYP3A4 or P-gp inhibitors, the dose must be reduced to prevent fatal toxicity 4:
- Patients on cyclosporine, clarithromycin, or protease inhibitors should receive maximum 0.3 mg once daily for prophylaxis 4
- Patients with renal or hepatic impairment should not receive colchicine with these inhibitors 4
Treatment Algorithm
- Confirm diagnosis: Establish pericarditis using ≥2 clinical criteria before starting colchicine 1
- Assess renal function: Calculate CrCl to determine appropriate dosing 1, 4
- Review medications: Check for CYP3A4/P-gp inhibitors requiring dose adjustment 4
- Weight-based dosing: Use 0.5 mg once daily (<70 kg) or twice daily (≥70 kg) 1, 2
- Always combine with NSAIDs: Never use colchicine as monotherapy 3, 2
- Monitor with CRP: Continue until symptoms resolve and CRP normalizes 1, 2
Common Pitfalls to Avoid
- Never exceed 1.0 mg/day in standard pericarditis treatment without specific indication 1, 2
- Never use standard doses in severe renal impairment (CrCl <30) - this can cause fatal toxicity 1, 4
- Never combine standard doses with strong CYP3A4 inhibitors (macrolides, statins increase toxicity risk) 5
- Never stop before 3 months for acute pericarditis - inadequate duration increases recurrence risk from 16.7% to 37.5% 1, 6
- Never use colchicine alone - it must be combined with aspirin or NSAIDs 3, 2
Safety Profile
Gastrointestinal intolerance is the most common side effect, occurring in 5-10% of patients 7, 8. This can be managed by:
The CORP-2 trial demonstrated that colchicine at these doses has similar adverse event rates to placebo (7% vs 7%) with no serious adverse events reported 9, 8.